Scribe Therapeutics Inc (SCTX)

NASD · Healthcare · Biotechnology · USA

Scribe Therapeutics Inc is a micro cap company (market value under $300 million) in the Biotechnology industry.

Intrinsic value, DCF valuation, financial health and value investing analysis for the Scribe Therapeutics Inc stock.

Our verdict on SCTX

Not valued: We cannot value this company yet.

ETFs with the most weight in SCTX

Browse

Peers in Biotechnology

All 600 Biotechnology stocks

Cheaper than SCTX in Biotechnology

129 more in this industry show a wider margin of safety.

Is SCTX undervalued or overvalued?

We do not publish a verdict on SCTX yet. We are missing a figure this valuation depends on. We would rather say so than show a number built on a guess.

What is the intrinsic value of SCTX?

We do not publish one (as of the 2026-11-17 close). We are missing a figure this valuation depends on. We would rather say so than show a number built on a guess.